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Summary
Purpose: Insulin responses to oral and intravenous glucose markedly differ by ethnicity. This study
examined whether ethnic differences in pancreatic insulin secretion, hepatic insulin extraction and clearance
explain these disparate findings in 35 obese African–American and 41 Latina girls (Tanner Stages: IV–V; ages:
14–18; body mass index percentile: 85.9–99.8%).
Methods: Pancreatic insulin secretion, hepatic insulin extraction and clearance were estimated by
C-peptide and insulin modeling during an oral glucose tolerance test. Insulin sensitivity (SI), acute insulin
response to glucose (AIRG) and disposition index were derived from a frequently sampled intravenous
glucose tolerance test.
Results: Compared to Latinas, obese African–American adolescents had lower pancreatic insulin secre-
tion (21.3%; P < 0.01), glucose incremental area under the curve (IAUC) (41.7%, P = 0.02), C-peptide IAUC
(25.1%, P < 0.01) and SI (33.7%; P < 0.01). There were no ethnic differences in hepatic insulin extraction and
clearance (P's > 0.05).
Conclusions: Compensatory mechanisms to insulin resistance do not appear to explain the ethnic
differences in insulin responses to oral and intravenous glucose in obese African–American and Latina girls.
Keywords: African–American, hepatic insulin extraction, Latina, pancreatic insulin secretion.
Insulin responses to intravenous and oral glucose
markedly differ by ethnicity. Previous research has
consistently reported a greater acute insulin
response to intravenous glucose (AIRG) (1,2) as well
as a greater insulin response to oral glucose inges-
tion in African–Americans compared to their Latino
(3) and non-Latino white counterparts (4). Our labo-
ratory recently demonstrated insulin sensitivity (SI),
derived from a frequently sampled intravenous
glucose tolerance test (FSIGT) was significantly lower
in obese African–American boys and girls compared
to Latinos, independent of total and visceral fat mass
(2). Moreover, pancreatic beta-cell function (as
reflected by a greater disposition index [DI]) and AIRG
was significantly higher in African–Americans com-
pared to Latinos (2). Interestingly, in the same group
of participants, the exaggerated insulin response
reported during the FSIGT was not observed during
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an oral glucose tolerance test (OGTT) (2). Specifically,
insulin incremental area under the curve (IAUC) was
similar in both ethnic groups (2).
One explanation for the greater AIRG in African–
Americans during the FSIGT may be related to ethnic
differences in the compensatory responses to insulin
resistance (5). We previously demonstrated that
African–American children display profound hyperin-
sulinemia in response to intravenous glucose, partly
explained by a lower hepatic insulin extraction,
whereas Latino children have an increased second
phase insulin secretion (5). It is unclear whether these
findings in normal weight African–American and
Latino children (Tanner stages I-III) are similar in a
more severely obese adolescent population, and
more importantly, whether or not these compensa-
tory mechanisms explain our disparate findings
between intravenous and oral glucose ingestion in
African–American youth. Therefore, the primary
objective of this study was to compare pancreatic
insulin secretion, hepatic insulin extraction and clear-
ance derived from an OGTT in obese African–
American and Latino adolescents at a later stage of
pubertal development (Tanner stages IV-V). It was
hypothesized that pancreatic insulin secretion would
be higher and/or hepatic insulin extraction and clear-
ance would be lower in African–Americans com-
pared to Latinos.
Participant characteristics and general procedures
used in this study have been previously reported
(1,2,6); however, the most relevant information is
described below. OGTT modeling data was only
completed in 51 African–Americans (16 males/35
females) and 66 Latinos (25 males/41 females);
therefore the present analysis is based on a subsam-
ple (females only) of the original study population. All
participants met the following inclusion criteria: age-
and gender-specific BMI  85th percentile, African–
American or Latino ethnicity (all four grandparents
were of the same ethnic group as the child in the
study), and attending grades 9th–12th grade
(approximately 14–18 years of age). The University
institutional review board approved this study.
Participants arrived at the University of Southern
California (USC) General Clinical Research Center
(GCRC) at ~7:30 am after completing an overnight
fast. Upon arrival, a licensed pediatric healthcare
provider conducted a medical/family history and
physical examination. Total body composition was
assessed using dual-energy X-ray absorptiometry
using a Hologic QDR 4500W (Hologic, Bedford, MA,
USA). Plasma glucose, insulin and C-peptide IAUC
were measured during a 3-h OGTT (2). The extended
Combined Model method was used to estimate pan-
creatic insulin secretion, hepatic insulin extraction
and clearance (7). Approximately 7–14 d after the
outpatient visit, participants were admitted to the
GCRC in the evening hours and completed a FSIGT
(2) the following morning.
Before analysis, data were evaluated for normality
and log transformed when necessary. Ethnic differ-
ences in physical characteristics were tested using
independent-sample t-tests and Chi-square tests.
Ethnic differences in body composition, OGTT and
FSIGT parameters were tested using analysis of cov-
ariance, after controlling for Tanner stage, sex, total
fat mass and fat-free mass. All analyses were per-
formed using SPSS version 18.0 (Chicago, IL, USA)
with significance level set at a < 0.05.
Participant characteristics are shown in Table 1.
Compared to Latinas, a smaller percentage of
African–Americans were in Tanner stage IV, had
higher body weight, fat-free mass and body fat per-
centage (all P's < 0.05). There were no significant
differences in age, body mass index (BMI), BMI
z-score, BMI percentile, total fat mass, impaired
fasting glucose and impaired glucose tolerance by
ethnicity (all P's < 0.05).
The values for the key variables from the OGTT and
FSIGT are shown in Table 2. During the OGTT,
African–Americans had significantly lower fasting
insulin and C-peptide values, glucose and C-peptide
IAUCs compared to Latinas (all P's < 0.05; see
Fig. 1). C-peptide-to-glucose ratio also tended to be
lower in African–Americans compared to Latinas
(P = 0.051). Pancreatic insulin secretion (P < 0.01)
was significantly lower in African–Americans com-
pared to Latinas; however, there were no significant
ethnic differences reported in fasting glucose, insulin
IAUC, hepatic insulin extraction and clearance (all
P's > 0.05). During the FSIGT, SI was significantly
lower in African–Americans compared with Latinas
(P = 0.02). AIRG and DI were 40 and 20% higher,
respectively, in African–Americans compared to
Latinas; however, these differences were not signifi-
cant (P's > 0.05).
Contrary to our hypotheses, this study demon-
strates that in response to oral glucose ingestion,
pancreatic insulin secretion is significantly lower in
obese African–American girls compared to their
Latina counterparts. Acknowledging that glucose is a
major stimulus for pancreatic insulin secretion, we
also examined the ratio of C-peptide-to-glucose
concentrations during the OGTT. Again, African–
Americans had a lower C-peptide-to-glucose ratio
than compared to Latina girls (P = 0.051). These
findings are generally consistent with our previous
findings (5) and confirm increased secretion is the
Compensatory responses to IR | e69
S
H
O
R
T
C
O
M
M
U
N
IC
A
T
IO
N
© 2013 The Authors
Pediatric Obesity © 2013 International Association for the Study of Obesity. Pediatric Obesity 8, e68–e73
primary mechanism by which obese Latina girls
compensate for insulin resistance.
Hepatic insulin extraction and clearance were
similar in both ethnic groups. These findings are in
contrast to our previous findings where normal
weight African–American children had significantly
lower hepatic insulin extraction and clearance com-
pared to Latino children (5). It is possible that with
greater obesity, the ability of the liver to compensate
for insulin resistance by reducing insulin extraction in
African–Americans becomes compromised (8).
Although this compensatory mechanism may be
able to maintain the already low levels of insulin sen-
sitivity in normal weight African–American youth in
Table 1 Participant
characteristics African–Americans
(n = 35)
Latinas (n = 41) P-value
Tanner stage (%) <0.01
Stage IV 5.7 34.1
Stage V 94.3 65.9
Age (years) 15.5  0.2 15.3  0.2 0.51
Weight (kg) 93.9  3.7 84.7  2.7 0.05
BMI (kg/m2) 35.1  1.2 33.2  0.9 0.24
BMI z-score 2.1  0.7 2.0  0.7 0.31
BMI percentile 97.3  0.5 96.5  0.6 0.27
Fat-free mass (kg) 53.9  1.4 47.8  1.1 <0.01
Fat mass (kg) 35.5  2.1 34.5  1.6 0.70
Percentage of body fat 38.6  1.0 41.2  0.8 <0.01
IFG (%) 5.7 7.3 0.78
IGT (%) 11.4 22.0 0.23
IFG and IGT (%) 2.9 2.4 0.91
Data are unadjusted mean  standard error. Significant at p < 0.05. BMI, body mass index; IFG-impaired fasting glucose;
IGT-impaired glucose tolerance. P-values reflect significant differences by ethnicity and were calculated using chi-square
and Student's t-tests. While unadjusted means are reported here for all variables, analyses were based on log scores for
age, weight, BMI and BMI percentile.
Table 2 OGTT and
FSIGT parameters
for African–American
and Latina girls
African–Americans
(n = 35)
Latinas
(n = 41)
P-value
OGTT
Fasting glucose (mmol/L) 5.0  0.1 5.0  0.1 0.32
Fasting insulin (pmol/L) 160.36  14.4 182.7  11.2 <0.01
Fasting C-peptide (nmol/L) 0.9  0.1 1.1  0.1 <0.01
Glucose IAUC (nmol/min/L) 74.6  7.1 105.7  7.7 0.02
Insulin IAUC (nmol/min/L) 347.3  43.1 393.6  35.4 0.13
C-peptide IAUC (nmol/min/L) 21.5  1.6 26.9  1.5 <0.01
Ratio C-peptide:glucose concentrations 0.09  0.005 0.10  0.004 0.05
Pancreatic insulin Secretion (nmol/min) 895.6  112.2 1088.1  108.0 <0.01
Hepatic insulin extraction (%) 55.7  2.3 60.5  2.1 0.24
Fractional disappearance of insulin
(% per min)
38.5  2.5 36.6  1.9 0.66
FSIGT
Insulin sensitivity (x 10-4 min-1/pmol/L) 8.6  0.9 11.5  0.9 0.02
AIRG (pmol/L x 10 min) 15998.7  1886.1 9558.6  672.3 0.16
DI (x 10-4 min-1) 2264.2  241.9 1813.8  110.5 0.08
Data are mean  standard error. Significant at P < 0.05. OGTT, oral glucose tolerance test; IAUC, incremental area under
the curve; FSIGT, frequently sampled intravenous glucose tolerance test; AIR, acute insulin response to glucose; DI,
disposition index. Analyses were based on log scores for fasting glucose, fasting insulin, pancreatic insulin secretion,
hepatic insulin extraction, fractional disappearance of insulin, insulin sensitivity, AIR and DI. P-values reflect significant
differences by ethnicity and were calculated using analyses of covariance, covarying for Tanner stage, total fat, fat-free mass
and insulin sensitivity (for AIRG and pancreatic secretion only).
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Figure 1 Incremental area under
the curves during the oral glucose
tolerance test for (a) glucose,
(b) insulin and (c) C-peptide.
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the short term, with greater obesity this mechanism
may eventually lead to failure of the beta-cell and
progression towards type 2 diabetes in this ethnic
group. Further research using a longitudinal design is
needed to better examine the pathophysiology of
type 2 diabetes progression in African–American
youth.
Interestingly, FSIGT measures of insulin sensitivity
demonstrate African–Americans were more insulin
resistant compared to Latinas, whereas lower pan-
creatic insulin secretion, glucose and C-peptide
IAUCs during the OGTT suggest African–Americans
are more insulin sensitive. There are several factors
that may explain these disparate findings. First, pre-
vious research has reported lower Glucagon-like
peptide-1 (GLP-1) levels in response to oral glucose
ingestion in obese African–American adolescents
compared to non-Latino whites (4,9), thus highlight-
ing the potential role for ethnic differences in incretin
hormones. However to date, no study has compared
incretin responses in African–American and Latina
girls. Second, it is also plausible that these disparate
OGTT and FSIGT findings are explained by the dif-
ferent methods in which glucose was administered
(ingestion vs. intravenous, respectively) (10). Previous
research has reported differences by test type in
pancreatic secretory responses and pancreatic beta-
cell rate of exposure to nutrients (10). Therefore, it is
likely that intravenous and oral glucose tests capture
unique aspects of the insulin response. Specifically,
the higher AIRG (within the first few minutes) previ-
ously observed in obese African–Americans during
the FSIGT may be the result of the immediate release
of previously docked insulin secretory granules on
the beta-cell (10,11), whereas the rapid depletion of
these granules and greater reliance on granule trans-
port may drive insulin and C-peptide responses
during the OGTT. Hence, these findings emphasize
the importance of understanding test-related differ-
ences in the assessment of insulin and C-peptide
dynamics when examining ethnic differences in type
2 diabetes risk in obese African–American and Latino
adolescents. Several limitations of this study should
be noted. First, data limitations precluded analysis
of other factors known to influence insulin and
C-peptide dynamics in this analysis including genetic
admixture (12). In addition, the poor reproducibility of
the OGTT has been previously noted (13) and the
reliance on mathematical modeling of insulin sensi-
tivity and secretion rather than direct measurements
(14) may have influenced the interpretation of the
present findings. Finally, given the large variability in
OGTT- and FSIGT-derived insulin and glucose
indices, some of our analyses may have been under-
powered, inhibiting our ability to generalize our find-
ings to other populations. Despite these limitations,
we were able to replicate some of our previous find-
ings and detect significant differences in pancreatic
insulin secretion, glucose and C-peptide IAUCs
between obese African–American and Latina girls.
Future research should continue to address the
question of underlying mechanisms that contribute
to metabolic abnormalities in obese African–
American and Latino adolescents.
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